Reagent price increases from dollar strength
Vendors have requested price increases due to dollar appreciation; if sustained, margins could be pressured unless passed on.
medium · analyst_question
Thyrocare Technologies Ltd — Q4 FY26
Thyrocare delivered a strong Q4 FY26 with consolidated revenue of ₹224 crore (+20% YoY) and PAT of ₹48.7 crore (+128% YoY), driven by 21% growth in franchisee business and 23% i...
bullish
high
✓ Verified against BSE filing
Risk Intelligence
Material risks this quarter
Concise cards keep the risk register scannable while preserving evidence-level context in the underlying quarter data.
Risks
Partnership business growth dip due to one-off normalization
Q4 partnership growth slowed to 23% due to normalization of insurance pricing and lower camp volumes; management attributes it to a one-off but it may recur.
low · management_commentaryTanzania business still loss-making
Tanzania operations have not yet broken even after 18 months, with quarterly losses of ~₹1 crore, though minimal.
low · analyst_questionSpecialty expansion may pressure near-term margins
Investments in specialty (genomics, allergy) will have lower gross margins initially, potentially weighing on overall profitability until scale is achieved.
medium · data_observation